ArticleInternational journal of obesity (2005)2026
Butyrylcholinesterase as a potential biomarker of metabolic imbalances in Afro-descendant populations.
Article in International journal of obesity (2005), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
26 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study investigated butyrylcholinesterase (BChE) activity and its genetic variants (-116, A, and K) in Afro-Brazilian individuals living in two African-derived communities (quilombos) in southern Brazil. Parameters, including obesity, glucose, and lipid profile, were compared with those of Euro-Brazilian individuals from the same region. The study aimed to characterize population parameters and assess their influence on factors involved in metabolic syndrome, obesity, and type 2 diabetes mellitus (TDM2).
methodsA total of 198 Afro-Brazilians and 114 Euro-Brazilians participated. BChE activity was measured using the Ellman method, and variants were genotyped by PCR-SSP. Statistical analyses included t-test or Mann-Whitney, ANOVA, chi-square or Fisher's exact test, correlations, and age- and sex-adjusted regression models.
resultsThe mean BChE activity in the Quilombola population was 3.71 U/mL and was significantly higher in people with TDM2 and/or obesity (p = 0.016), and associated with triglycerides, total cholesterol, overweight, and male sex. A significant interaction between triglycerides and glycated hemoglobin was observed (p = 0.016). BChE activity was higher in Quilombolas than in Euro-Brazilians, regardless of metabolic status, suggesting ethnic influence. BCHE gene variants (A, -116, and K) showed frequencies similar to other populations. Although enzymatic activity varied among haplotypes, differences were not statistically significant. These results highlight the relevance of clinical and ethnic factors in interpreting BChE activity.
conclusionsThis study revealed higher BChE activity and TDM2 prevalence in Afro-Brazilian populations compared to Euro-Brazilians, and these differences correlate with non-genetic factors. The BCHE genetic variants investigated showed no robust associations after correction for multiple testing, suggesting that their effects on metabolic traits may be subtle and context-dependent. This is the first study to quantify BChE activity in Afro-Brazilian Quilombola populations and the second in Black individuals in Brazil, highlighting the importance of considering genetic and ethnic factors in metabolic risk assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.